AngioDynamics第四季度调整后每股亏损0.03美元

华尔街洞察
Jul 15

医疗技术企业AngioDynamics最新财报显示,公司第四季度实现销售额8020万美元。当季调整后每股亏损为0.03美元,这一表现超出市场预期——相较市场普遍预期的每股亏损0.05美元,实际亏损幅度明显收窄。

尽管仍处于亏损状态,但每股亏损收窄的态势凸显出公司在成本管控和运营效率方面的持续改进。最新财务数据于新加坡时间7月15日下午6时30分由权威财经信息平台发布。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10